Trial Profile
A Multicenter Randomized Evaluator-Blinded Vehicle-Controlled Parallel Group Evaluation of Twice Daily PDI-320 in Comparison to Its Monads in Adults With Rosacea
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2014
Price :
$35
*
At a glance
- Drugs PDI 320 (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors PreCision Dermatology
- 27 Mar 2014 New trial record